Profile for Novavax, Inc (NVAX)

Company

Financials

Insiders

Filings

Analyst

Earnings

Historical

Profile · Share Information · Key Ratios

Symbol:

Profile for Novavax Inc. (NVAX)

After Hours: $ 1.83

0.02 (+1.10%)

Volume: 700

4:13 PM EST Dec 2, 2008

Business Description:
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Address:

9920 Belward Campus Drive, Rockville, MD 20850

Telephone:

(240) 268-2000

Website:

www.novavax.com

Facsimile:

(484) 931-0150

Email:

ir@novavax.com

Details

CEO:

Dr. Rahul Singhvi

Employees:

Market Cap:

125.2 m

Issue Type:

Auditor:

Grant Thornton LLP

Last Audit:

Indices:

Biotechnology , Russell 2000

Industry Classifications

Sector:

Healthcare

CIK:

0001000694

Industry:

Drugs

NAICS:

Biological Product (except Diagnostic) Manufacturing (325414)

QM ID:

Biotechnology(515)

SIC:

Biological Products, Except Diagnostic Substances (2836)

Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia, profiles by Morningstar. Terms of Use.